D. Boral Capital Stock Recommendations and Price Targets

This is a list of recent ratings by D. Boral Capital.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
1/7/2025
AREC
American Resources
Reiterated Rating$1.00$4.00 ➝ $4.00Buy ➝ BuyN/A
1/7/2025
IMUX
Immunic
Reiterated Rating$1.00$17.00 ➝ $17.00Buy ➝ BuyN/A
1/7/2025
HOTH
Hoth Therapeutics
Reiterated Rating$2.00$5.00 ➝ $5.00Buy ➝ BuyN/A
1/7/2025
CTXR
Citius Pharmaceuticals
Reiterated Rating$4.00$9.00 ➝ $9.00Buy ➝ BuyN/A
1/6/2025
PAPL
Pineapple Financial
Lower Price Target$1.00$5.50 ➝ $5.00Buy ➝ BuyN/A
1/6/2025
NRXP
NRx Pharmaceuticals
Reiterated Rating$5.00$31.00 ➝ $31.00Buy ➝ BuyN/A
1/6/2025
IBRX
ImmunityBio
Reiterated Rating$3.00$30.00 ➝ $30.00Buy ➝ BuyN/A
1/6/2025
NNOX
Nano-X Imaging
Initiated Coverage$9.00 $23.00BuyN/A
1/3/2025
LCTX
Lineage Cell Therapeutics
Reiterated Rating$1.00$2.00 ➝ $2.00Buy ➝ BuyN/A
1/3/2025
CTSO
Cytosorbents
Reiterated Rating$1.00$10.00 ➝ $10.00Buy ➝ BuyN/A
1/3/2025
USEG
U.S. Energy
Reiterated Rating$2.00$2.00 ➝ $2.00Buy ➝ BuyN/A
1/2/2025
QNCX
Quince Therapeutics
Reiterated Rating$2.00$12.00 ➝ $12.00Buy ➝ BuyN/A
12/31/2024
NRXP
NRx Pharmaceuticals
Reiterated Rating$5.00$31.00 ➝ $31.00Buy ➝ BuyN/A
12/31/2024
CANF
Can-Fite BioPharma
Reiterated Rating$2.00$10.00 ➝ $10.00Buy ➝ BuyN/A
12/30/2024
HOVR
New Horizon Aircraft
Reiterated Rating$1.00$2.00 ➝ $2.00Buy ➝ BuyN/A
12/30/2024
CTXR
Citius Pharmaceuticals
Upgrade$4.00 $9.00Hold ➝ BuyN/A
12/27/2024
FBLG
FibroBiologics
Reiterated Rating$2.00$16.00 ➝ $16.00Buy ➝ BuyN/A
12/24/2024
RCEL
AVITA Medical
Initiated Coverage$14.00 $25.00BuyN/A
12/23/2024
CMPX
Compass Therapeutics
Initiated Coverage$1.00 $32.00BuyN/A
12/23/2024
AVXL
Anavex Life Sciences
Reiterated Rating$13.00$46.00 ➝ $46.00Buy ➝ BuyN/A
12/23/2024
OMER
Omeros
Initiated Coverage$10.00 $36.00BuyN/A
12/20/2024
IBRX
ImmunityBio
Reiterated Rating$3.00$30.00 ➝ $30.00Buy ➝ BuyN/A
12/20/2024
RZLV
Rezolve AI
Reiterated Rating$4.00$8.00 ➝ $8.00Buy ➝ BuyN/A
12/20/2024
HUMA
Humacyte
Reiterated Rating$5.00$25.00 ➝ $25.00Buy ➝ BuyN/A
12/19/2024
IMNN
Imunon
Reiterated Rating$1.00$29.00 ➝ $29.00Buy ➝ BuyN/A
12/19/2024
CLNN
Clene
Reiterated Rating$6.00$23.00 ➝ $23.00Buy ➝ BuyN/A
12/18/2024
GOVX
GeoVax Labs
Reiterated Rating$2.00$18.00 ➝ $18.00Buy ➝ BuyN/A
12/18/2024
COYA
Coya Therapeutics
Reiterated Rating$6.00$15.00 ➝ $15.00Buy ➝ BuyN/A
12/17/2024
TTI
TETRA Technologies
Reiterated Rating$4.00$5.50 ➝ $5.50Buy ➝ BuyN/A
12/17/2024
BMEA
Biomea Fusion
Reiterated Rating$4.00$128.00 ➝ $128.00Buy ➝ BuyN/A
12/16/2024
ICFI
ICF International
Reiterated Rating$116.00$174.00 ➝ $174.00Outperform ➝ OutperformN/A
12/12/2024
TRVI
Trevi Therapeutics
Reiterated Rating$4.00$21.00 ➝ $21.00Buy ➝ BuyN/A
12/11/2024
ENLV
Enlivex Therapeutics
Reiterated Rating$1.00$13.00 ➝ $13.00Buy ➝ BuyN/A
12/10/2024
VNRX
VolitionRx
Reiterated Rating$1.00$5.00 ➝ $5.00Buy ➝ BuyN/A
12/10/2024
IMNN
Imunon
Reiterated Rating$1.00$29.00 ➝ $29.00Buy ➝ BuyN/A
12/10/2024
CLNN
Clene
Reiterated Rating$6.00$23.00 ➝ $23.00Buy ➝ BuyN/A
12/10/2024
BMEA
Biomea Fusion
Reiterated Rating$4.00$128.00 ➝ $128.00Buy ➝ BuyN/A
12/10/2024
CRVO
CervoMed
Reiterated Rating$2.00Buy ➝ HoldN/A
12/9/2024
CARM
Carisma Therapeutics
Lower Price Target$1.00$24.00 ➝ $12.00Buy ➝ BuyN/A
12/9/2024
ARTL
Artelo Biosciences
Reiterated Rating$1.00$6.00 ➝ $6.00Buy ➝ BuyN/A
12/6/2024
URGN
UroGen Pharma
Reiterated Rating$11.00$25.00 ➝ $25.00Buy ➝ BuyN/A
12/5/2024
CANF
Can-Fite BioPharma
Reiterated Rating$2.00$10.00 ➝ $10.00Buy ➝ BuyN/A
12/4/2024
TRVI
Trevi Therapeutics
Reiterated Rating$4.00$21.00 ➝ $21.00Buy ➝ BuyN/A
12/4/2024
COYA
Coya Therapeutics
Initiated Coverage$6.00 $15.00BuyN/A
12/3/2024
ENLV
Enlivex Therapeutics
Reiterated Rating$1.00$13.00 ➝ $13.00Buy ➝ BuyN/A
12/2/2024
MNOV
MediciNova
Initiated Coverage$2.00$9.00 ➝ $9.00Buy ➝ BuyN/A
11/27/2024
CLGN
CollPlant Biotechnologies
Reiterated Rating$4.00$14.00 ➝ $14.00Buy ➝ BuyN/A
11/27/2024
CRVO
CervoMed
Reiterated Rating$2.00$34.00 ➝ $34.00Buy ➝ BuyN/A
11/25/2024
IMNN
Imunon
Reiterated Rating$1.00$29.00 ➝ $29.00Buy ➝ BuyN/A
11/25/2024
CNTX
Context Therapeutics
Initiated Coverage$1.00 $9.00BuyN/A
11/25/2024
AVXL
Anavex Life Sciences
Reiterated Rating$13.00$46.00 ➝ $46.00Buy ➝ BuyN/A
11/22/2024
CTXR
Citius Pharmaceuticals
Reiterated Rating$4.00Buy ➝ HoldN/A
11/21/2024
IVVD
Invivyd
Reiterated Rating$1.00$9.00 ➝ $9.00Buy ➝ BuyN/A
11/21/2024
AREC
American Resources
Reiterated Rating$1.00$4.00 ➝ $4.00Buy ➝ BuyN/A
11/21/2024
HUMA
Humacyte
Reiterated Rating$5.00$25.00 ➝ $25.00Buy ➝ BuyN/A
11/21/2024
IBRX
ImmunityBio
Reiterated Rating$3.00$30.00 ➝ $30.00Buy ➝ BuyN/A
11/20/2024
LCTX
Lineage Cell Therapeutics
Lower Price Target$1.00$3.00 ➝ $2.00Buy ➝ BuyN/A
11/20/2024
PED
PEDEVCO
Lower Price Target$1.00$2.25 ➝ $1.50Buy ➝ BuyN/A
11/20/2024
FBLG
FibroBiologics
Reiterated Rating$2.00$16.00 ➝ $16.00Buy ➝ BuyN/A
11/19/2024
GOVX
GeoVax Labs
Reiterated Rating$2.00$18.00 ➝ $18.00Buy ➝ BuyN/A
11/19/2024
ANIX
Anixa Biosciences
Reiterated Rating$2.00$10.00 ➝ $10.00Buy ➝ BuyN/A
11/19/2024
BMEA
Biomea Fusion
Reiterated Rating$4.00$128.00 ➝ $128.00Buy ➝ BuyN/A